Big Pharma
Coverage of Big Pharma in the Nexus archive.
- Big pharma warns Germany’s attempts to curb drug prices will backfire
Big pharma has warned that attempts by Germany to curb drug prices may backfire. Conversely, a government source stated that implementing higher mandatory discounts for insurers is predicted to save €12bn by 2030.
- Opinion | Hold right industry accountable for unaffordable health care: Big Pharma
The opinion piece calls for holding the right industry accountable for making health care unaffordable, specifically targeting Big Pharma. It is authored by Dr. Adam C. Hunt, an emergency medicine physician, and Dr. Emily Hurst, an intensivist.
- The $400bn megadeal brewing in big pharma
AstraZeneca and Bristol Myers Squibb are in talks that could result in a $400bn merger, creating the world’s fourth-largest drugmaker by market value.
- Comcast Pulls AI Ad After Blackburn Accuses Dark Money PAC of Defamation
Comcast withdrew an AI-generated ad accusing Senator Marsha Blackburn of accepting bribes from Big Pharma, following legal threats from her attorneys. The ad, produced by a dark-money PAC, uses AI to depict Blackburn as complicit in pharmaceutical industry corruption, prompting demands to cease distribution and potential legal action.
- Biotech deals surge to record as fear of missing out grips Big Pharma
Biotech deals have surged to a record high as Big Pharma experiences fear of missing out, driven by the impending expiration of patents on profitable drugs, prompting pharmaceutical companies to seek new blockbuster medicines.
- The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley signals growing pharmaceutical industry interest in psychedelic drugs for mental health treatment. The move reflects broader acceptance of this previously stigmatized medication class.
- Incyte strikes up to $2bn deal for blood disorder biotech
Incyte has agreed to a potential $2 billion deal for a biotech company specializing in blood disorders. Mid-sized drug manufacturers are enhancing their pipelines and increasing competition with major pharmaceutical companies.
- ‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid
Biotech mergers and acquisitions in 2026 are experiencing a strong start, driven by patent cliffs, rising public market confidence, and pharmaceutical companies seeking to enhance their drug pipelines.
- Dozens of MPs oppose Streeting’s new power to say what NHS pays for drugs
Health Secretary Wes Streeting faces opposition from 31 MPs over granting himself authority to override Nice's drug pricing decisions for the NHS. Critics argue the move may be illegal and favor pharmaceutical companies.
- Fitness guru Jillian Michaels opens up about skipping school for Taco Bell runs during food addiction
Fitness guru Jillian Michaels discussed her past food addiction, including skipping school for Taco Bell meals, and her advocacy against processed foods. She highlighted lobbying groups like Big Ag and Big Food as barriers to health reform.